Dongguan Eontec Co Ltd

Eontec announced that its degradable magnesium interference screw project has completed enrollment of all 130 subjects according to the clinical trial protocol. Over 70 of them have completed one-year postoperative follow-up, and imaging and clinical function assessments show stable fixation. The company will subsequently submit a product registration application and, upon approval, launch the product for sale, which is expected to fill a gap in the domestic market for degradable metal orthopedic implant consumables.

Dongguan Yian Technology Co., Ltd. has received a government grant of 2.432 million yuan for a national major industrial software project. The grant is related to income and accounts for 13.79 percent of the absolute value of the company's net profit attributable to parent company shareholders in the most recent audited fiscal year. The company received the payment on July 28, 2026, and will record it as other income, with an estimated impact on profit and loss of 2.432 million yuan. The company stated that the grant will help it deeply align with the national strategy for independent and controllable industrial software, accumulate core technologies, and enhance its core competitive advantage in the field of domestic industrial software substitution. The above data is unaudited, and the final accounting treatment will be subject to the audit confirmation results.